How common is Prostate cancer?

Ixhaphake kangakanani umhlaza wedlala lesinyi?

Umhlaza wesinyi yenye yezona ntlobo zomhlaza zixhaphakileyo emadodeni, ingakumbi amadoda amadala.

Ngokutsho kweAmerican Cancer Society, umhlaza wedlala lesinyi ngowesibini umhlaza oqhelekileyo kumadoda aseMerika, emva komhlaza wolusu.

EUnited States, malunga nomntu omnye kwabasithoba baya kufunyaniswa benomhlaza wedlala lesinyi ngexesha lokuphila kwabo.

Ngo-2021, kuqikelelwa ukuba kuza kubakho abantu abatsha abamalunga nama-248 530 abanomhlaza wedlala lesinyi kunye nokufa kwabantu abamalunga nama-34 130 ngenxa yomhlaza wedlala lesinyi.

Noko ke, kubalulekile ukuphawula ukuba umhlaza wedlala lesinyi unokunyangwa yaye xa ubonwe kwangethuba, unokuphilisa abantu abaninzi.

['Iimbekiselo']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R: Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiol Biomarkers Prev. 2009, 18 (3): 808-15.

Peng P, Gong YM, Bao PP, Ke JZ, Xiang YM, Zhang ML, Zheng Y: [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012, 33 (10): 1056-9.

Delongchamps NB, Singh A, Haas GP: The role of prevalence in the diagnosis of prostate cancer. Cancer Control. 2006, 13 (3): 158-68.

Li J, German R, King J, Joseph D, Thompson T, Wu XC, Ajani U, Tai E: Recent trends in prostate cancer testing and incidence among men under age of 50. Cancer Epidemiol. 2012, 36 (2): 122-7.

Yu XQ, Luo Q, Smith DP, Clements MS, O'Connell DL: Prostate cancer prevalence in New South Wales Australia: a population-based study. Cancer Epidemiol. 2015, 39 (1): 29-36.

Ondrusova M, Mrozova L, Ondrus D, Mrinakova B: Trends and estimates in prostate cancer incidence, mortality and prevalence in the Slovak Republic, 1968-2012. Neoplasma. 2013, 60 (4): 446-51.

['Ukuzikhusela: unyango']

['Le webhsayithi yenzelwe ukufundisa nokunika inkcazelo kuphela yaye ayibonisi ukuba inikela amacebiso ezonyango okanye iinkonzo zobungcali.']

['Inkcazelo enikelweyo ayifanele isetyenziselwe ukuxilonga okanye ukunyanga ingxaki yempilo okanye isifo, yaye abo bafuna icebiso lonyango lobuqu bafanele babonane nogqirha onelayisensi.']

['Nceda uqaphele ukuba inethiwekhi ye-neural eyenza iimpendulo kwimibuzo, ayichanekanga xa kufikwa kumxholo wenani. Umzekelo, inani labantu abafunyaniswe benesifo esithile.']

['Soloko ucela icebiso kugqirha wakho okanye komnye umboneleli wezempilo ofanelekileyo malunga nemeko yakho yezonyango. Ungaze ungayihoyi ingcebiso yezonyango okanye ulibazise ukufuna ngenxa yento oyifunde kule webhusayithi. Ukuba ucinga ukuba unengxaki yezonyango, tsalela umnxeba ku-911 okanye uye kwigumbi likaxakeka elikufutshane ngoko nangoko. Akukho buhlobo bukagqirha nomguli obudalwa yile webhusayithi okanye ukusetyenziswa kwayo. I-BioMedLib okanye abasebenzi bayo, okanye nabani na onegalelo kule webhusayithi, abenzi zimelo, ngokucacileyo okanye ngokungangqalanga, ngokubhekisele kulwazi olunikezwe apha okanye ekusetyenzisweni kwalo.']

['Ukuzikhulula: ilungelo lokushicilela']

['Umthetho we-Digital Millennium Copyright ka-1998, 17 U.S.C. § 512 (i-DMCA) ubonelela ngeendlela zokubhena kubanini bamalungelo obunini abakholelwa ukuba izinto ezibonakala kwi-Intanethi ziphula amalungelo abo phantsi komthetho welungelo lokushicilela wase-US. ']

['Ukuba ukholelwa ukuba kukho umxholo okanye izinto ezenziwe zafumaneka kwi-website yethu okanye iinkonzo eziphula ilungelo lakho lokushicilela, wena (okanye iarhente yakho) ungathumela isaziso esicela ukuba umxholo okanye izinto zisuswe, okanye ukufikelela kuzo kuvalwe. ']

['Izaziso kufuneka zithunyelwe ngokubhaliweyo nge-imeyile (jonga kwicandelo elithi "Qhagamshelana" ukuze ufumane idilesi ye-imeyile).']

['I-DMCA ifuna ukuba isaziso sakho sokutyholwa ngokophula ilungelo lokushicilela siquke ezi nkcukacha zilandelayo: (1) inkcazelo yomsebenzi onelungelo lokushicilela ongundaba-mlonyeni wokutyholwa ngokophula; (2) inkcazelo yomxholo otyholwa ngokophula kunye nolwazi olwaneleyo ukusivumela ukuba sifumane umxholo; (3) iinkcukacha zokuqhagamshelana nawe, kuquka idilesi yakho, inombolo yomnxeba nedilesi ye-imeyile; (4) ingxelo yakho yokuba unokholo olulungileyo lokuba umxholo ngendlela ekhalazwa ngayo awugunyaziswanga ngumnini welungelo lokushicilela, okanye iarhente yakhe, okanye ngokusebenza kwawo nawuphi na umthetho; ']

['(5) ingxelo yakho, esayinwe phantsi kwesohlwayo sobuxoki, yokuba ulwazi olukwisibhengezo luchanekile kwaye unegunya lokunyanzelisa amalungelo okushicilela ekuthiwa aphulwe;']

['kwaye (6) utyikityo lomzimba okanye lwe-elektroniki lomnini welungelo lokushicilela okanye lomntu ogunyazisiweyo ukuba enze egameni lomnini welungelo lokushicilela. ']

['Ukungabandakanyi lonke ulwazi olungentla kungakhokelela ekulibaziseni ukuphathwa kwesikhalazo sakho.']

['Unxibelelwano']

['Nceda usithumelele i-imeyile ngayo nayiphi na imibuzo / iingcebiso.']

How common is prostate cancer?

Prostate cancer is one of the most common types of cancer in men, particularly in older men.

According to the American Cancer Society, prostate cancer is the second most common cancer in American men, behind skin cancer.

In the United States, about 1 in 9 men will be diagnosed with prostate cancer during their lifetime.

In 2021, it is estimated that there will be about 248,530 new cases of prostate cancer and about 34,130 deaths from prostate cancer.

However, it is important to note that prostate cancer is highly treatable, and the survival rate is high when it is detected early.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.